GO:1903301 positive regulation of hexokinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903301 describes any process that activates or increases the frequency, rate or extent of hexokinase activity, the first committed step of glycolysis.
• Hexokinase 2 (HK2) is the most studied isoform in this context, and its upregulation supports aerobic glycolysis in cancer and immune cells.
• Positive regulation of hexokinase activity is achieved through transcriptional induction, post-translational modification, and allosteric modulation by metabolites.
• The process is implicated in trastuzumab resistance in gastric cancer, hepatocellular carcinoma immune evasion, and tumor blood vessel abnormalities.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of hexokinase regulators.
• EDITGENE provides end-to-end CRISPR cell model generation and library screening to study positive regulation of hexokinase activity in disease contexts.
Description
Hexokinase catalyzes the ATP-dependent phosphorylation of glucose to glucose-6-phosphate, the first committed and rate-limiting step of glycolysis. The Gene Ontology term GO:1903301, positive regulation of hexokinase activity, captures any biological process that increases the frequency, rate, or extent of this enzymatic activity. Because hexokinase activity sets the pace of glucose flux, its positive regulation is central to metabolic reprogramming in proliferating cells, immune activation, and parasite energy metabolism. Researchers study this term to understand how cells meet biosynthetic and energetic demands under stress, and how dysregulation contributes to cancer, metabolic disorders, and infectious disease. The term encompasses regulation of all hexokinase isoforms, including HK1, HK2, HK3, and glucokinase (HK4), and is distinct from general glycolytic regulation because it specifically targets the activation step of hexokinase enzymes.
positive regulation of hexokinase activity At A Glance
| GO ID | GO:1903301 |
|---|---|
| GO term | positive regulation of hexokinase activity |
| Ontology | biological_process |
| Synonym | activation of hexokinase activity; upregulation of hexokinase activity; positive regulation of ATP-dependent hexokinase activity |
| Major function | Increases the rate of glucose phosphorylation to glucose-6-phosphate, promoting glycolytic flux |
| Regulated entities | Hexokinase 1 (HK1), hexokinase 2 (HK2), hexokinase 3 (HK3), glucokinase (HK4/GCK) |
| Upstream regulators | Transcription factors (e.g., AHR, NF-kB), circadian proteins (PER1), and metabolic signals |
| Disease relevance | Cancer, metabolic reprogramming, immune evasion, parasite metabolism |
What Is GO:1903301?
GO:1903301 is a biological process term defined as any process that activates or increases the frequency, rate or extent of hexokinase activity. In practice, this includes transcriptional upregulation of hexokinase genes, stabilization of hexokinase proteins, post-translational modifications that enhance catalytic efficiency, and allosteric or metabolic conditions that promote substrate turnover. It does not cover inhibition or negative regulation, which are separate GO terms. The term applies across eukaryotes and some protozoan parasites, reflecting the conserved importance of hexokinase control in glucose metabolism.
Why Is positive regulation of hexokinase activity Important in Cell Biology?
Positive regulation of hexokinase activity is a metabolic checkpoint that determines how much glucose enters glycolysis and downstream biosynthetic pathways. In cancer, increased hexokinase activity supports the Warburg effect and resistance to therapy, as shown in gastric cancer where disrupting the PER1-HK2 axis reverses trastuzumab resistance. In immune cells, hexokinase-driven glycolysis is required for T cell metabolic fitness and antitumor immunity. In parasites such as Trypanosoma brucei and Trypanosoma cruzi, hexokinase regulation is critical for survival and is a potential drug target. Thus, understanding GO:1903301 provides mechanistic insight into diseases and opportunities for therapeutic intervention.
• Controls the first committed step of glycolysis, affecting ATP production and biosynthetic precursors.
• Supports aerobic glycolysis (Warburg effect) in cancer cells, contributing to tumor growth and therapy resistance.
• Required for T cell metabolic fitness and effective antitumor immunity.
• Modulates fibroblast activation and tissue remodeling via aerobic glycolysis.
• Influences tumor blood vessel abnormalities through pericyte contractility.
• Plays a role in parasite energy metabolism, offering antiparasitic targets.
• Linked to circadian rhythm regulation via PER1-HK2 axis.
• Involved in AHR signaling, connecting metabolism to xenobiotic responses.
• Provides a node for crosstalk between NF-kB signaling and metabolism.
• Serves as a biomarker and therapeutic target in multiple cancers.
What Happens During positive regulation of hexokinase activity?
Transcriptional induction of hexokinase genes
In simple terms: Cells make more hexokinase mRNA when they need to boost glucose breakdown.
Positive regulation often begins with increased transcription of HK genes. For example, HK2 is a transcriptional target of AHR signaling, and its induction enhances glycolytic flux. In gastric cancer, the circadian protein PER1 regulates HK2 expression, and disrupting this axis alters hexokinase activity. NF-kB-inducing kinase supports T cell metabolic fitness partly by maintaining hexokinase expression.
Post-translational modifications and protein stability
In simple terms: Chemical tags on hexokinase can make it work harder or last longer.
Phosphorylation, ubiquitination, and acetylation can modulate hexokinase activity and stability. For instance, HK2 is subject to regulation by signaling pathways that affect its degradation or catalytic efficiency. In Trypanosoma cruzi, hexokinase activity displays hysteresis and positive cooperativity, suggesting complex post-translational and allosteric control.
Allosteric and metabolic modulation
In simple terms: Small molecules can bind hexokinase and change its shape to increase activity.
Metabolites such as glucose-6-phosphate, inorganic phosphate, and ATP/ADP ratios allosterically influence hexokinase. In Trypanosoma brucei, hexokinase and phosphofructokinase activities are regulated by glycolytic intermediates. Positive cooperativity in T. cruzi hexokinase suggests that substrate binding itself can enhance activity.
Interaction with mitochondria and cellular structures
In simple terms: Hexokinase can dock onto mitochondria, which helps it work better.
Binding of hexokinase, especially HK2, to the outer mitochondrial membrane via VDAC enhances its catalytic activity and couples glycolysis to oxidative phosphorylation. This interaction is important in cancer cells and pericytes, where HK2-driven glycolysis affects contractility and blood vessel abnormalities. Disruption of this interaction reduces hexokinase activity and glycolytic flux.
Integration with signaling pathways
In simple terms: Growth and stress signals tell cells to rev up hexokinase.
Signaling cascades such as NF-kB, AHR, and circadian pathways converge on hexokinase regulation. NF-kB-inducing kinase maintains hexokinase activity in T cells. AHR signaling is positively modulated by HK2, creating a feed-forward loop. In hepatocellular carcinoma, SRSF10 affects M2 macrophage polarization and may influence metabolic genes including hexokinase.
Key Genes Involved in GO:1903301 positive regulation of hexokinase activity
The following genes and proteins are central to the positive regulation of hexokinase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HK1 | Hexokinase isoform 1, ubiquitously expressed, binds mitochondria | Model for constitutive glycolysis; knockout viable but metabolic defects |
| HK2 | Hexokinase isoform 2, inducible, key in cancer and immune cells | Target for cancer therapy; PER1-HK2 axis in trastuzumab resistance |
| HK3 | Hexokinase isoform 3, low affinity, expressed in some tissues | Less studied; potential role in specific cancers |
| GCK (HK4) | Glucokinase, liver and pancreatic beta cells, glucose sensor | Mutations cause MODY2; regulation differs from other hexokinases |
| PER1 | Circadian clock protein, regulates HK2 expression | Disrupting PER1-HK2 axis reverses trastuzumab resistance |
| AHR | Aryl hydrocarbon receptor, transcription factor | HK2 is a transcriptional target and positive modulator of AHR signaling |
| NIK (MAP3K14) | NF-kB-inducing kinase, maintains T cell metabolic fitness | Links NF-kB signaling to hexokinase activity in antitumor immunity |
| SRSF10 | Splicing factor, affects M2 macrophage polarization | Targeting SRSF10 might inhibit M2 polarization in HCC |
| MrgD | Alamandine receptor, regulates aerobic glycolysis | Alamandine/MrgD axis prevents fibroblast activation via glycolysis |
| VDAC | Voltage-dependent anion channel, binds hexokinase | Mitochondrial docking enhances hexokinase activity |
| PFK | Phosphofructokinase, downstream glycolytic enzyme | Co-regulated with hexokinase in Trypanosoma brucei |
| HIF-1alpha | Hypoxia-inducible factor, induces glycolytic genes | Often upstream of HK2 induction in cancer |
| c-Myc | Oncogenic transcription factor, activates glycolysis | Drives HK2 expression in many cancers |
| p53 | Tumor suppressor, can repress glycolysis | Loss of p53 may enhance hexokinase activity |
| AMPK | Energy sensor, modulates glycolysis | Can affect hexokinase activity indirectly |
| mTOR | Growth signaling kinase, promotes glycolysis | Upstream of hexokinase regulation |
| G6PD | Glucose-6-phosphate dehydrogenase, downstream of hexokinase | Competes for glucose-6-phosphate; affects flux |
| LDHA | Lactate dehydrogenase A, downstream of glycolysis | Marker of aerobic glycolysis |
How Is positive regulation of hexokinase activity Regulated?
Positive regulation of hexokinase activity is controlled at multiple levels. Transcriptionally, growth factor signaling via mTOR and NF-kB induces HK2 expression. The circadian protein PER1 directly regulates HK2, linking metabolic cycles to circadian rhythm. AHR signaling forms a positive feedback loop with HK2, enhancing its own activity. Post-translationally, hexokinase activity can be modulated by phosphorylation and ubiquitination, though specific E3 ligases remain under study. Allosterically, metabolites such as glucose-6-phosphate and inorganic phosphate fine-tune activity. In parasites, unique regulatory mechanisms like hysteresis and positive cooperativity control hexokinase.
positive regulation of hexokinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HK2 | Gastric cancer, trastuzumab resistance | HK2 knockout or point-mutation in gastric cancer cell lines |
| SRSF10 | Hepatocellular carcinoma, M2 macrophage polarization | SRSF10 knockout in HCC cells and macrophage co-culture |
| MrgD | Fibrosis, fibroblast activation | MrgD overexpression or knockout in fibroblasts |
| NIK | T cell metabolic fitness, antitumor immunity | NIK knockout in T cells followed by metabolic assays |
| AHR | Xenobiotic response, cancer | AHR knockout or overexpression with HK2 reporter |
Cancer and therapy resistance
Increased hexokinase activity supports aerobic glycolysis in cancer cells, contributing to tumor growth and resistance to therapies. In gastric cancer, disrupting the PER1-HK2 axis reverses trastuzumab resistance, highlighting the clinical relevance of positive regulation of hexokinase activity. In hepatocellular carcinoma, targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy, potentially through metabolic reprogramming. Hexokinase 2-driven glycolysis in pericytes leads to tumor blood vessel abnormalities, affecting drug delivery and tumor progression.
Immune metabolism and antitumor immunity
T cell metabolic fitness depends on hexokinase activity. NF-kB-inducing kinase maintains hexokinase expression and glycolytic flux, supporting antitumor immunity. Modulating hexokinase activity could enhance T cell-based therapies. In macrophages, SRSF10 affects M2 polarization, which is linked to altered glucose metabolism.
Fibrosis and tissue remodeling
The Alamandine/MrgD axis prevents TGF-beta1-mediated fibroblast activation via regulation of aerobic glycolysis and mitophagy, implicating hexokinase activity in fibrotic diseases. Positive regulation of hexokinase may promote fibroblast activation and extracellular matrix deposition.
Parasitic infections
Trypanosoma brucei and Trypanosoma cruzi rely on glycolysis for energy, and their hexokinases are regulated differently from human enzymes. Understanding positive regulation in these parasites could lead to selective inhibitors.
From positive regulation of hexokinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HK2 reduce glycolytic flux and tumor growth? | HK2 knockout cell lines and xenografts |
| Does a specific phosphorylation site on HK2 regulate its activity? | Point-mutation knock-in of phospho-deficient or phospho-mimetic HK2 |
| Does overexpression of HK2 enhance therapy resistance? | HK2 overexpression in sensitive cancer cell lines |
| How does NIK regulate hexokinase activity in T cells? | NIK knockout mice or T cell-specific knockout |
| Does AHR signaling feedback on HK2 expression? | AHR knockout with HK2 promoter reporter |
| Can CRISPR library screening identify novel regulators of hexokinase activity? | Genome-wide CRISPR knockout library in cells with hexokinase activity reporter |
How to Study the positive regulation of hexokinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Hexokinase activity assay | Enzymatic conversion of glucose to glucose-6-phosphate | Quantify positive regulation in cell lysates |
| RNA-seq | mRNA levels of HK genes | Assess transcriptional induction |
| ChIP-seq | Transcription factor binding to HK promoters | Identify direct regulators like AHR |
| Phosphoproteomics | Phosphorylation sites on hexokinase | Discover post-translational modifications |
| Seahorse assay | Extracellular acidification rate (glycolysis) | Measure glycolytic flux in live cells |
| 13C-glucose tracing | Metabolic flux through glycolysis | Quantify hexokinase step in intact cells |
| CRISPR library screening | Genes affecting hexokinase activity | Identify novel regulators |
| Western blot | Hexokinase protein levels | Confirm overexpression or knockout |
Measuring hexokinase activity
Enzymatic assays using glucose and ATP coupled to NADP+ reduction via glucose-6-phosphate dehydrogenase are standard. These assays can be performed in cell lysates or with purified protein to assess positive regulation.
Transcriptional analysis
RNA-seq and qPCR can quantify HK1, HK2, HK3, and GCK mRNA levels. ChIP-seq can identify transcription factor binding at hexokinase promoters, as shown for AHR and HK2.
Proteomics and post-translational modification mapping
Mass spectrometry-based proteomics can detect phosphorylation, acetylation, and ubiquitination of hexokinases. This helps identify modifications that enhance activity.
Metabolic flux analysis
Seahorse extracellular flux analysis and 13C-glucose tracing measure glycolytic rate and flux through hexokinase. These methods are used to assess the impact of genetic perturbations.
How CRISPR Can Be Used to Study GO:1903301 positive regulation of hexokinase activity
Knockout
CRISPR knockout of HK2 or upstream regulators (e.g., PER1, NIK) can abolish positive regulation of hexokinase activity, leading to reduced glycolysis and altered phenotypes. For example, HK2 knockout reverses trastuzumab resistance in gastric cancer cells. NIK knockout impairs T cell metabolic fitness.
Point Mutation
Point mutations can be introduced to test specific phosphorylation sites or catalytic residues. For instance, mutating a phosphorylation site on HK2 can determine whether it is required for enhanced activity. This approach helps distinguish causal residues from bystander modifications.
Knock-in
Knock-in of tagged hexokinase (e.g., FLAG-HK2) allows for immunoprecipitation and interaction studies. Knock-in of mutant hexokinase with altered activity can model disease-associated variants. This is useful for studying allosteric regulation.
Overexpression
Overexpression of HK2 or upstream activators (e.g., AHR) can drive positive regulation of hexokinase activity, increasing glycolytic flux and promoting phenotypes such as therapy resistance. Overexpression models are valuable for gain-of-function studies.
How EDITGENE Supports positive regulation of hexokinase activity Research
Researchers studying positive regulation of hexokinase activity-related genes often need to determine whether a candidate gene is causally involved in hexokinase activation, glycolytic flux, and disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to enable such investigations with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of hexokinase activity research.
Frequently Asked Questions About positive regulation of hexokinase activity
What is GO:1903301?
GO:1903301 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of hexokinase activity, the first step of glycolysis.
What genes are involved in positive regulation of hexokinase activity?
Key genes include HK1, HK2, HK3, GCK (HK4), and upstream regulators such as PER1, AHR, NIK, and SRSF10.
How is hexokinase activity positively regulated?
It is regulated transcriptionally (e.g., by AHR, PER1), post-translationally (phosphorylation, ubiquitination), and allosterically by metabolites.
Why is hexokinase 2 important in cancer?
HK2 is often overexpressed in cancer, supports aerobic glycolysis, and contributes to therapy resistance, as shown in gastric cancer.
What diseases are associated with increased hexokinase activity?
Cancer, fibrosis, and parasitic infections are linked to increased hexokinase activity.
How can I study positive regulation of hexokinase activity?
Use enzymatic assays, RNA-seq, ChIP-seq, metabolic flux analysis, and CRISPR knockout or overexpression models.
What CRISPR models are available for hexokinase research?
Knockout, point mutation, knock-in, and overexpression models can be generated for HK genes and regulators.
Does hexokinase activity affect immune cells?
Yes, hexokinase-driven glycolysis is required for T cell metabolic fitness and antitumor immunity.
What is the role of PER1 in hexokinase regulation?
PER1 regulates HK2 expression; disrupting the PER1-HK2 axis reverses trastuzumab resistance in gastric cancer.
How does AHR signaling relate to hexokinase?
HK2 is a transcriptional target and positive modulator of AHR signaling, forming a feedback loop.
Conclusion
Positive regulation of hexokinase activity (GO:1903301) is a critical metabolic control point with broad implications in cancer, immunology, fibrosis, and parasitology. Understanding its molecular players and regulatory mechanisms offers opportunities for therapeutic intervention. CRISPR-based cell models and functional genomics are indispensable tools for dissecting this process. EDITGENE provides comprehensive services to support such research, from knockout to library screening.
References
- 1. Cai J et al.. 2024. Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma.. Cancer Commun (Lond) 44(11):1231-1260 PMID: 39223929
- 2. Wang J et al.. 2022. Disrupting Circadian Rhythm via the PER1-HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer.. Cancer Res 82(8):1503-1517 PMID: 35255118
- 3. Wang W et al.. 2023. Alamandine/MrgD axis prevents TGF-β1-mediated fibroblast activation via regulation of aerobic glycolysis and mitophagy.. J Transl Med 21(1):24 PMID: 36635651
- 4. Meng YM et al.. 2021. Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities.. Nat Commun 12(1):6011 PMID: 34650057
- 5. Gu M et al.. 2021. NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.. Nat Immunol 22(2):193-204 PMID: 33398181
- 6. Nwagwu M et al.. 1982. Regulation of glycolysis in Trypanosoma brucei: hexokinase and phosphofructokinase activity.. Acta Trop 39(1):61-72 PMID: 6122364
- 7. Acosta H et al.. 2014. Hysteresis and positive cooperativity as possible regulatory mechanisms of Trypanosoma cruzi hexokinase activity.. Mol Biochem Parasitol 198(2):82-91 PMID: 25683029
- 8. Watzky M et al.. 2022. Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling.. Nucleic Acids Res 50(10):5545-5564 PMID: 35609998
